Patents by Inventor Santosh Kumar Guru

Santosh Kumar Guru has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fused pyrimidines as isoform selective phosphoinositide-3-kinase-alpha inhibitors and process for preparation thereof
    Patent number: 10696688
    Abstract: The present invention relates to fused pyrimidines of formulae I and II wherein, R1, R2 are as herein described. The present invention particularly relates to isoform selective PI3K? inhibition and their medicinal use as anticancer agents.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: June 30, 2020
    Assignee: Council of Scientific & Industrial Research
    Inventors: Sandip Bibishan Bharate, Shashi Bhushan, Shabber Mohammed, Santosh Kumar Guru, Sonali Sandip Bharate, Vikas Kumar, Girish Mahajan, Mubashir Javed Mintoo, Dilip Manikrao Mondhe, Ram Vishwakarma
  • FUSED PYRIMIDINES AS ISOFORM SELECTIVE PHOSPHOINOSITIDE-3-KINASE-ALPHA INHIBITORS AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20200031845
    Abstract: The present invention relates to fused pyrimidines of formulae I and II wherein, R1, R2 are as herein described. The present invention particularly relates to isoform selective PI3K? inhibition and their medicinal use as anticancer agents.
    Type: Application
    Filed: November 21, 2016
    Publication date: January 30, 2020
    Inventors: Sandip Bibishan BHARATE, Shashi BHUSHAN, Shabber MOHAMMED, Santosh Kumar GURU, Sonali Sandip BHARATE, Vikas KUMAR, Girish MAHAJAN, Mubashir Javed MINTOO, Dilip Manikrao MONDHE, Ram VISHWAKARMA
  • 6-aryl-4-phenylamino-quinazoline analogs as phosphoinositide-3-kinase inhibitors
    Patent number: 10202374
    Abstract: The present invention relates to 6-aryl-4-phenylamino quinazolines of formula I wherein, R and R? are as herein described. The present invention particularly relates to synthesis and anticancer and phoshpoinositide-3-kinase-? (PI3K-?) inhibitory activity. In addition, the invention relates to methods of using compounds for treating or preventing various cancers such as pancreatic, prostate, breast and melanoma.
    Type: Grant
    Filed: February 16, 2015
    Date of Patent: February 12, 2019
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Ram Asrey Vishwakarma, Sandip Bibishan Bharate, Shashi Bhushan, Rammohan Rao Yadav, Santosh Kumar Guru, Prashant Joshi
  • 6-ARYL-4-PHENYLAMINO-QUINAZOLINE ANALOGS AS PHOSPHOINOSITIDE-3-KINASE INHIBITORS
    Publication number: 20170015662
    Abstract: The present invention relates to 6-aryl-4-phenylamino quinazolines of formula I wherein, R and R? are as herein described. The present invention particularly relates to synthesis and anticancer and phoshpoinositide-3-kinase-? (PI3K-?) inhibitory activity. In addition, the invention relates to methods of using compounds for treating or preventing various cancers such as pancreatic, prostate, breast and melanoma.
    Type: Application
    Filed: February 16, 2015
    Publication date: January 19, 2017
    Applicant: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Ram Asrey Vishwakarma, Sandip Bibishan Bharate, Shashi Bhushan, Rammohan Rao Yadav, Santosh Kumar Guru, Prashant Joshi